Global Axial Spondyloarthritis Drugs Sales Market Report 2017

REPORT ID 3590

Global Axial Spondyloarthritis Drugs Sales Market Report 2017

Publish Date

14-Dec-17

Pages

104

Format

Electronic (PDF)

Full report description

In this report, the global Axial Spondyloarthritis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Axial Spondyloarthritis Drugs for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Axial Spondyloarthritis Drugs market competition by top manufacturers/players, with Axial Spondyloarthritis Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca Plc
    Eli Lilly and Company
    Johnson & Johnson
    Novartis AG
    Panacea Biotec Ltd
    Sandoz International GmbH
    Sun Pharma Advanced Research Company Ltd
    UCB SA
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Certolizumab Pegol
    Etanercept Biosimilar
    Ixekizumab
    Secukinumab
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Clinic
    Hospital
    Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of contents

Table of Contents

Global Axial Spondyloarthritis Drugs Sales Market Report 2017
1 Axial Spondyloarthritis Drugs Market Overview
    1.1 Product Overview and Scope of Axial Spondyloarthritis Drugs
    1.2 Classification of Axial Spondyloarthritis Drugs by Product Category
        1.2.1 Global Axial Spondyloarthritis Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Axial Spondyloarthritis Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Certolizumab Pegol
        1.2.4 Etanercept Biosimilar
        1.2.5 Ixekizumab
        1.2.6 Secukinumab
        1.2.7 Others
    1.3 Global Axial Spondyloarthritis Drugs Market by Application/End Users
        1.3.1 Global Axial Spondyloarthritis Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Home Care
    1.4 Global Axial Spondyloarthritis Drugs Market by Region
        1.4.1 Global Axial Spondyloarthritis Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Axial Spondyloarthritis Drugs Status and Prospect (2012-2022)
        1.4.3 China Axial Spondyloarthritis Drugs Status and Prospect (2012-2022)
        1.4.4 Europe Axial Spondyloarthritis Drugs Status and Prospect (2012-2022)
        1.4.5 Japan Axial Spondyloarthritis Drugs Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Axial Spondyloarthritis Drugs Status and Prospect (2012-2022)
        1.4.7 India Axial Spondyloarthritis Drugs Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Axial Spondyloarthritis Drugs (2012-2022)
        1.5.1 Global Axial Spondyloarthritis Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Axial Spondyloarthritis Drugs Revenue and Growth Rate (2012-2022)

2 Global Axial Spondyloarthritis Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Axial Spondyloarthritis Drugs Market Competition by Players/Suppliers
        2.1.1 Global Axial Spondyloarthritis Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Axial Spondyloarthritis Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Axial Spondyloarthritis Drugs (Volume and Value) by Type
        2.2.1 Global Axial Spondyloarthritis Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Axial Spondyloarthritis Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Axial Spondyloarthritis Drugs (Volume and Value) by Region
        2.3.1 Global Axial Spondyloarthritis Drugs Sales and Market Share by Region (2012-2017)
        2.3.2 Global Axial Spondyloarthritis Drugs Revenue and Market Share by Region (2012-2017)
    2.4 Global Axial Spondyloarthritis Drugs (Volume) by Application

3 United States Axial Spondyloarthritis Drugs (Volume, Value and Sales Price)
    3.1 United States Axial Spondyloarthritis Drugs Sales and Value (2012-2017)
        3.1.1 United States Axial Spondyloarthritis Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Axial Spondyloarthritis Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Axial Spondyloarthritis Drugs Sales Price Trend (2012-2017)
    3.2 United States Axial Spondyloarthritis Drugs Sales Volume and Market Share by Players
    3.3 United States Axial Spondyloarthritis Drugs Sales Volume and Market Share by Type
    3.4 United States Axial Spondyloarthritis Drugs Sales Volume and Market Share by Application

4 China Axial Spondyloarthritis Drugs (Volume, Value and Sales Price)
    4.1 China Axial Spondyloarthritis Drugs Sales and Value (2012-2017)
        4.1.1 China Axial Spondyloarthritis Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Axial Spondyloarthritis Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Axial Spondyloarthritis Drugs Sales Price Trend (2012-2017)
    4.2 China Axial Spondyloarthritis Drugs Sales Volume and Market Share by Players
    4.3 China Axial Spondyloarthritis Drugs Sales Volume and Market Share by Type
    4.4 China Axial Spondyloarthritis Drugs Sales Volume and Market Share by Application

5 Europe Axial Spondyloarthritis Drugs (Volume, Value and Sales Price)
    5.1 Europe Axial Spondyloarthritis Drugs Sales and Value (2012-2017)
        5.1.1 Europe Axial Spondyloarthritis Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Axial Spondyloarthritis Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Axial Spondyloarthritis Drugs Sales Price Trend (2012-2017)
    5.2 Europe Axial Spondyloarthritis Drugs Sales Volume and Market Share by Players
    5.3 Europe Axial Spondyloarthritis Drugs Sales Volume and Market Share by Type
    5.4 Europe Axial Spondyloarthritis Drugs Sales Volume and Market Share by Application

6 Japan Axial Spondyloarthritis Drugs (Volume, Value and Sales Price)
    6.1 Japan Axial Spondyloarthritis Drugs Sales and Value (2012-2017)
        6.1.1 Japan Axial Spondyloarthritis Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Axial Spondyloarthritis Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Axial Spondyloarthritis Drugs Sales Price Trend (2012-2017)
    6.2 Japan Axial Spondyloarthritis Drugs Sales Volume and Market Share by Players
    6.3 Japan Axial Spondyloarthritis Drugs Sales Volume and Market Share by Type
    6.4 Japan Axial Spondyloarthritis Drugs Sales Volume and Market Share by Application

7 Southeast Asia Axial Spondyloarthritis Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Axial Spondyloarthritis Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Axial Spondyloarthritis Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Axial Spondyloarthritis Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Axial Spondyloarthritis Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Axial Spondyloarthritis Drugs Sales Volume and Market Share by Players
    7.3 Southeast Asia Axial Spondyloarthritis Drugs Sales Volume and Market Share by Type
    7.4 Southeast Asia Axial Spondyloarthritis Drugs Sales Volume and Market Share by Application

8 India Axial Spondyloarthritis Drugs (Volume, Value and Sales Price)
    8.1 India Axial Spondyloarthritis Drugs Sales and Value (2012-2017)
        8.1.1 India Axial Spondyloarthritis Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Axial Spondyloarthritis Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Axial Spondyloarthritis Drugs Sales Price Trend (2012-2017)
    8.2 India Axial Spondyloarthritis Drugs Sales Volume and Market Share by Players
    8.3 India Axial Spondyloarthritis Drugs Sales Volume and Market Share by Type
    8.4 India Axial Spondyloarthritis Drugs Sales Volume and Market Share by Application

9 Global Axial Spondyloarthritis Drugs Players/Suppliers Profiles and Sales Data
    9.1 AstraZeneca Plc
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Axial Spondyloarthritis Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 AstraZeneca Plc Axial Spondyloarthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Eli Lilly and Company
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Axial Spondyloarthritis Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Eli Lilly and Company Axial Spondyloarthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Johnson & Johnson
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Axial Spondyloarthritis Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Johnson & Johnson Axial Spondyloarthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Novartis AG
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Axial Spondyloarthritis Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Novartis AG Axial Spondyloarthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Panacea Biotec Ltd
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Axial Spondyloarthritis Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Sandoz International GmbH
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Axial Spondyloarthritis Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Sandoz International GmbH Axial Spondyloarthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Sun Pharma Advanced Research Company Ltd
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Axial Spondyloarthritis Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 UCB SA
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Axial Spondyloarthritis Drugs Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 UCB SA Axial Spondyloarthritis Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview

10 Axial Spondyloarthritis Drugs Maufacturing Cost Analysis
    10.1 Axial Spondyloarthritis Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Axial Spondyloarthritis Drugs
    10.3 Manufacturing Process Analysis of Axial Spondyloarthritis Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Axial Spondyloarthritis Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Axial Spondyloarthritis Drugs Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Axial Spondyloarthritis Drugs Market Forecast (2017-2022)
    14.1 Global Axial Spondyloarthritis Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Axial Spondyloarthritis Drugs Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Axial Spondyloarthritis Drugs Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Axial Spondyloarthritis Drugs Price and Trend Forecast (2017-2022)
    14.2 Global Axial Spondyloarthritis Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Axial Spondyloarthritis Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Axial Spondyloarthritis Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Axial Spondyloarthritis Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Axial Spondyloarthritis Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Axial Spondyloarthritis Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Axial Spondyloarthritis Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Axial Spondyloarthritis Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Axial Spondyloarthritis Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Axial Spondyloarthritis Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Axial Spondyloarthritis Drugs Sales Forecast by Type (2017-2022)
       14.3.2 Global Axial Spondyloarthritis Drugs Revenue Forecast by Type (2017-2022)
       14.3.3 Global Axial Spondyloarthritis Drugs Price Forecast by Type (2017-2022)
    14.4 Global Axial Spondyloarthritis Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer